Maravai Lifesciences Holdings (MRVI) Change in Receivables (2020 - 2026)

Maravai Lifesciences Holdings' Change in Receivables history runs 7 years deep, the most recent figure standing at $7.9 million for Q1 2026.

• In Q1 2026, Change in Receivables rose 177.89% year-over-year to $7.9 million; the TTM figure through Mar 2026 stood at $5.3 million (up 179.23% YoY), while the FY2025 annual figure was -$12.8 million, up 10.75% from the prior year.
• Change in Receivables for Q1 2026 stood at $7.9 million, up from $3.0 million in the prior quarter.
• The five-year high for Change in Receivables was $25.8 million in Q4 2022, with the low at -$82.4 million in Q1 2023.
• The 5-year median for Change in Receivables is -$1.9 million (2024), against an average of -$4.8 million.
• The sharpest annual moves came in 2023 and 2026: Change in Receivables slumped 6674.78% in 2023, then soared 177.89% in 2026.
• Maravai Lifesciences Holdings' Change in Receivables stood at $25.8 million in 2022, then tumbled by 65.92% to $8.8 million in 2023, then soared by 30.11% to $11.4 million in 2024, then plunged by 74.09% to $3.0 million in 2025, then jumped by 167.27% to $7.9 million in 2026.
• Business Quant data shows MRVI's Change in Receivables at $7.9 million in Q1 2026, $3.0 million in Q4 2025, and -$5.1 million in Q3 2025.